Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER)

2020293 citationsJournal Articlebronze Open Access

Authors

Sachin Kheterpal · Merck & Co., Inc., Rahway, NJ, USA (United States)

Michelle T. Vaughn · School of the Art Institute of Chicago

Timur Dubovoy · School of the Art Institute of Chicago

Nirav Shah · School of the Art Institute of Chicago

Lori D. Bash · School of the Art Institute of Chicago

Douglas A. Colquhoun · School of the Art Institute of Chicago

Amy Shanks

Abstract

Among a generalizable cohort of adult patients undergoing inpatient surgery at U.S. hospitals, the use of sugammadex was associated with a clinically and statistically significant lower incidence of major pulmonary complications.

Topics & Keywords

Anesthesia and Sedative Agents Cardiac, Anesthesia and Surgical Outcomes Intensive Care Unit Cognitive Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Anesthesiology

Volume 132, Issue 6, pp. 1371-1381

DOI: 10.1097/aln.0000000000003256

Field-Weighted Citation Impact: 47.87